Fiduciary Management Associates’s Emergent Biosolutions EBS Stock Holding History

Fiduciary Management Associates’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$18.8M	Sell	516,949 -156,140	-23%	-$5.52M	1.23%	51
2015 Q4	$26.9M	Sell	673,089 -44,280	-6%	-$1.54M	1.58%	3
2015 Q3	$20.4M	Sell	717,369 -58,825	-8%	-$1.94M	1.33%	35
2015 Q2	$25.6M	Buy	776,194 +9,770	+1%	+$303K	1.5%	15
2015 Q1	$22M	Sell	766,424 -2,710	-0.4%	-$77.7K	1.32%	41
2014 Q4	$20.9M	Buy	769,134 +117,250	+18%	+$2.79M	1.3%	37
2014 Q3	$13.9M	Buy	+651,884	New	+$14.9M	0.99%	74

Other funds holding EBS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fiduciary Management Associates's EBS Position: Q1 2016 in Review

Fiduciary Management Associates reduced its Emergent Biosolutions (EBS) stake by 23% in Q1 2016, selling an estimated $5.52M and leaving 516,949 shares worth $18.8M. The position accounts for 1.23% of the portfolio, ranked #51.

Fiduciary Management Associates first reported a position in EBS in Q3 2014 and has held it in 7 quarters since. The position peaked at $26.9M in Q4 2015. 214 funds tracked by Wall St. Rank hold EBS as of Q1 2016.

Fiduciary Management Associates held 516,949 shares of Emergent Biosolutions worth $18.8M as of Q1 2016.
Fiduciary Management Associates sold 156,140 Emergent Biosolutions shares in Q1 2016, an estimated $5.52M.
Emergent Biosolutions made up 1.23% of Fiduciary Management Associates's portfolio in Q1 2016, its #51 holding.
Fiduciary Management Associates first reported a position in Emergent Biosolutions in Q3 2014 and has held it in 7 quarters since.
Fiduciary Management Associates's Emergent Biosolutions position peaked at $26.9M in Q4 2015.
214 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2016.

Based on Fiduciary Management Associates's 13F filing for Q1 2016, filed 4 May 2016.